These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2217 related articles for article (PubMed ID: 11698225)

  • 21. Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantation.
    Yamagiwa S; Sato Y; Ichida T; Setsu T; Tominaga K; Kamimura H; Tsuchiya A; Takamura M; Matsuda Y; Aoyagi Y
    Biomed Res; 2014; 35(3):177-84. PubMed ID: 24942856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional subsets of mouse natural killer cells.
    Hayakawa Y; Huntington ND; Nutt SL; Smyth MJ
    Immunol Rev; 2006 Dec; 214():47-55. PubMed ID: 17100875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs.
    Fan YY; Yang BY; Wu CY
    Cell Biol Int; 2008 Feb; 32(2):188-97. PubMed ID: 17920947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69
    Marquardt N; Kekäläinen E; Chen P; Kvedaraite E; Wilson JN; Ivarsson MA; Mjösberg J; Berglin L; Säfholm J; Manson ML; Adner M; Al-Ameri M; Bergman P; Orre AC; Svensson M; Dahlén B; Dahlén SE; Ljunggren HG; Michaëlsson J
    J Allergy Clin Immunol; 2017 Apr; 139(4):1321-1330.e4. PubMed ID: 27670241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset.
    Harlin H; Hanson M; Johansson CC; Sakurai D; Poschke I; Norell H; Malmberg KJ; Kiessling R
    J Immunol; 2007 Oct; 179(7):4513-9. PubMed ID: 17878347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.
    Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C
    Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human CD56bright NK Cells: An Update.
    Michel T; Poli A; Cuapio A; Briquemont B; Iserentant G; Ollert M; Zimmer J
    J Immunol; 2016 Apr; 196(7):2923-31. PubMed ID: 26994304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
    Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
    Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.
    Romagnani C; Juelke K; Falco M; Morandi B; D'Agostino A; Costa R; Ratto G; Forte G; Carrega P; Lui G; Conte R; Strowig T; Moretta A; Münz C; Thiel A; Moretta L; Ferlazzo G
    J Immunol; 2007 Apr; 178(8):4947-55. PubMed ID: 17404276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset.
    Hayhoe RP; Henson SM; Akbar AN; Palmer DB
    Hum Immunol; 2010 Jul; 71(7):676-81. PubMed ID: 20394788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets.
    Mamessier E; Pradel LC; Thibult ML; Drevet C; Zouine A; Jacquemier J; Houvenaeghel G; Bertucci F; Birnbaum D; Olive D
    J Immunol; 2013 Mar; 190(5):2424-36. PubMed ID: 23359508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of CD56
    Casado JL; Moraga E; Vizcarra P; Velasco H; Martín-Hondarza A; Haemmerle J; Gómez S; Quereda C; Vallejo A
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CD16-/CD56bright subset of NK cells is resistant to oxidant-induced cell death.
    Thorén FB; Romero AI; Hermodsson S; Hellstrand K
    J Immunol; 2007 Jul; 179(2):781-5. PubMed ID: 17617567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD56
    Jaime P; García-Guerrero N; Estella R; Pardo J; García-Álvarez F; Martinez-Lostao L
    Osteoarthritis Cartilage; 2017 Oct; 25(10):1708-1718. PubMed ID: 28668542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human natural killer cell subsets and acute exercise: a brief review.
    Timmons BW; Cieslak T
    Exerc Immunol Rev; 2008; 14():8-23. PubMed ID: 19203081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The early expansion of anergic NKG2A
    Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
    Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
    Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
    Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant.
    Zhu L; Aly M; Wang H; Karakizlis H; Weimer R; Morath C; Kuon RJ; Toth B; Ekpoom N; Opelz G; Daniel V
    Clin Exp Immunol; 2018 Aug; 193(2):241-254. PubMed ID: 29679490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Human peripheral blood CD56+ natural killer cell subsets and their phenotypic and biological properties].
    Wu CY; Liu J; Yang BY; Roedere M
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):169-72. PubMed ID: 16875598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 111.